PBMs have sown dysfunction in the prescription drug market to the detriment of patients.
Congress has returned to Capitol Hill from summer recess. Lawmakers in both chambers have a full slate of policy priorities to attend to — not least among them funding the government and averting a shutdown before the Sept. 30 deadline.
Several healthcare items will also remain near the top of the to-do list. House Republicans , for instance, just put the finishing touches on a package that would, among other things, reform the practices of pharmacy benefit managers.
That’s a smart idea. PBMs have sown dysfunction in the prescription drug market to the detriment of patients.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.
Pharmacy benefit manager reform must remain a priority for Congress
Sally C. Pipes
PBMs have sown dysfunction in the prescription drug market to the detriment of patients.
Congress has returned to Capitol Hill from summer recess. Lawmakers in both chambers have a full slate of policy priorities to attend to — not least among them funding the government and averting a shutdown before the Sept. 30 deadline.
Several healthcare items will also remain near the top of the to-do list. House Republicans , for instance, just put the finishing touches on a package that would, among other things, reform the practices of pharmacy benefit managers.
That’s a smart idea. PBMs have sown dysfunction in the prescription drug market to the detriment of patients.
Read the full article at the Washington Examiner
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.